Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | PPARG | P37231 | 4/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | PPARD | Q03181 | 3/20 | 0.64 |
| ▸ | PPARA | Q07869 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11892066 | 0.97 | ALDH1A1 (0.67) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL25834788 | 0.97 | ALDH1A1 (0.67) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL21448748 | 0.97 | ALDH1A1 (0.67) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL24005588 | 0.97 | PPARG (0.64) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL20074366 | 0.97 | ALDH1A1 (0.67) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL23950453 | 0.97 | ALDH1A1 (0.67) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL21147476 | 0.95 | PPARG (0.66) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL17244735 | 0.93 | TOP1 (0.58) | ALDH1A1PPARGKDM4EPPARDPPARA | |
| SCHEMBL23950153 | 0.91 | TERT (0.63) | PPARGPPARDPPARALMNACYP3A4 | |
| SCHEMBL23950440 | 0.91 | TERT (0.63) | PPARGPPARDPPARALMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323992-A1 | GEMCITABINE PRODRUGS | CURE BIOPHARMA INC. | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323992-A1 | GEMCITABINE PRODRUGS | TYMP, PIK3CA, DCK | ALDH1A1 2877/4885PPARG 869/4885KDM4E 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.